Biotech entity
Every one of those 1 sits in a single category, pharma. Branchlab is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 3 original sources on average. We currently track 1 Biotech story that mention DeepIntent, all published on July 2, 2026.
Last mentioned: Jul 2, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. Branchlab is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 3 original sources on average. We currently track 1 Biotech story that mention DeepIntent, all published on July 2, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 1 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering DeepIntent. Shared-story counts are live from our verified record — not editorial picks.
FDA scrutiny and shifting spending are forcing pharma marketers to adopt specialized platforms. These tools navigate privacy rules while enabling precise targeting, but they fragment the ad tech landscape.
Source: digiday.com · Digiday
DeepIntent is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
